Newer drugs like semaglutide and tirzepatide can lead to significant weight loss, but often cause stomach issues like nausea, vomiting, diarrhea, or constipationespecially at the start
The most helpful lens for me is to think about it through the lens of the patient and extrapolate from there
The drug may no longer be FDA-approved
Risk factors that warrant additional consideration include: Being in the dose-escalation phase of semaglutide therapy Experiencing significant gastrointestinal symptoms (nausea, vomiting, fullness) Taking higher doses of the medication Having known gastroparesis or diabetic autonomic neuropathy For routine dental procedures such as cleanings, fillings, or simple extractions performed with local anesthesia only, semaglutide does not pose additional risks, and patients can continue their regular medication schedule
Glutathione Research L-Glutathione is widely used in biochemical and cellular research
Insulin allows sugar to move from the blood into cells, where it is used for energy
